Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors

Details for Australian Patent Application No. 2007238019 (hide)

Owner Abbott Laboratories

Inventors Kotecki, Brian J.; Fernando, Dilinie P.; Lukin, Kirill A.; Chi-Ping Hsu, Margaret; Leanna, Marvin R.

Agent Spruson & Ferguson

Pub. Number AU-A-2007238019

PCT Pub. Number WO2007/121339

Priority 60/792,099 14.04.06 US

Filing date 13 April 2007

Wipo publication date 25 October 2007

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/121339 Priority application(s): WO2007/121339

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238027-RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

2007238017-Devices, systems and methods for measuring and evaluating the motion and function of joint structures and associated muscles, determining suitability for orthopedic intervention, and evaluating efficacy of orthopedic intervention